BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moradi-Kalbolandi S, Majidzadeh-A K, Abdolvahab MH, Jalili N, Farahmand L. The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development. Probiotics Antimicrob Proteins 2021;13:1239-53. [PMID: 33770348 DOI: 10.1007/s12602-021-09773-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghulam U, Nazim F, Farooqui N, Rizwan-Ul-Hasan S, Anwar MF, Ahmed K, Jamal A, Kayani HA, Mughal N, Hussain A, Sarria-Santamera A, Abidi SH. Analysis of differential gene expression of pro-inflammatory cytokines in the nasopharyngeal milieu of mild & severe COVID-19 cases. PLoS One 2022;17:e0279270. [PMID: 36584119 DOI: 10.1371/journal.pone.0279270] [Reference Citation Analysis]
2 Kazemifard N, Dehkohneh A, Baradaran Ghavami S. Probiotics and probiotic-based vaccines: A novel approach for improving vaccine efficacy. Front Med (Lausanne) 2022;9:940454. [PMID: 36313997 DOI: 10.3389/fmed.2022.940454] [Reference Citation Analysis]
3 Singh S, Singh M, Gaur S. Probiotics as multifaceted oral vaccines against colon cancer: A review. Front Immunol 2022;13:1002674. [DOI: 10.3389/fimmu.2022.1002674] [Reference Citation Analysis]
4 Jaisue J, Nii T, Suzuki N, Tsugami Y, Isobe N. Effect of repeated intrauterine infusion of lipopolysaccharides on mastitis in goats. Theriogenology 2022;193:87-92. [PMID: 36156428 DOI: 10.1016/j.theriogenology.2022.09.009] [Reference Citation Analysis]
5 Gutierrez-Camacho JR, Avila-Carrasco L, Martinez-Vazquez MC, Garza-Veloz I, Zorrilla-Alfaro SM, Gutierrez-Camacho V, Martinez-Fierro ML. Oral Lesions Associated with COVID-19 and the Participation of the Buccal Cavity as a Key Player for Establishment of Immunity against SARS-CoV-2. Int J Environ Res Public Health 2022;19. [PMID: 36141654 DOI: 10.3390/ijerph191811383] [Reference Citation Analysis]
6 Levit R, Cortes-Perez NG, de Moreno de Leblanc A, Loiseau J, Aucouturier A, Langella P, LeBlanc JG, Bermúdez-Humarán LG. Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health. Gut Microbes 2022;14:2110821. [PMID: 35960855 DOI: 10.1080/19490976.2022.2110821] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Romero-Luna HE, Hernández-Mendoza A, González-Córdova AF, Peredo-Lovillo A. Bioactive peptides produced by engineered probiotics and other food-grade bacteria: A review. Food Chem X 2022;13:100196. [PMID: 35498967 DOI: 10.1016/j.fochx.2021.100196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Lee MH, Kim BJ. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity. J Microbiol 2022;60:321-34. [PMID: 35157221 DOI: 10.1007/s12275-022-1621-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alu A, Chen L, Lei H, Wei Y, Tian X, Wei X. Intranasal COVID-19 vaccines: From bench to bed. EBioMedicine 2022;76:103841. [PMID: 35085851 DOI: 10.1016/j.ebiom.2022.103841] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 80.0] [Reference Citation Analysis]
10 Xavier-Santos D, Padilha M, Fabiano GA, Vinderola G, Gomes Cruz A, Sivieri K, Costa Antunes AE. Evidences and perspectives of the use of probiotics, prebiotics, synbiotics, and postbiotics as adjuvants for prevention and treatment of COVID-19: A bibliometric analysis and systematic review. Trends Food Sci Technol 2022;120:174-92. [PMID: 35002079 DOI: 10.1016/j.tifs.2021.12.033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 32.0] [Reference Citation Analysis]
11 Fernández-Ferreiro A, Formigo-Couceiro FJ, Veiga-Gutierrez R, Maldonado-Lobón JA, Hermida-Cao AM, Rodriguez C, Bañuelos O, Olivares M, Blanco-Rojo R. Effects of Loigolactobacillus coryniformis K8 CECT 5711 on the Immune Response of Elderly Subjects to COVID-19 Vaccination: A Randomized Controlled Trial. Nutrients 2022;14:228. [PMID: 35011103 DOI: 10.3390/nu14010228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Chatterjee SK, Saha S, Munoz MNM. Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19. Explor Immunol 2021. [DOI: 10.37349/ei.2021.00025] [Reference Citation Analysis]
13 Chen J, Vitetta L, Henson JD, Hall S. The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. J Funct Foods 2021;87:104850. [PMID: 34777578 DOI: 10.1016/j.jff.2021.104850] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Scarpellini E, Scarcella L, Romanelli G, Basilico M, Lattanzi E, Rasetti C, Abenavoli L, Santori P. Nutritional Status and the Critically Ill Patient: Gut Microbiota and Immuno-Nutrition in I.C.U. at the Time of SARS-COV 2 Pandemic. Gastroenterology Insights 2021;12:259-69. [DOI: 10.3390/gastroent12020022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]